retatrutide vision loss Side Effects: What Patients Should Know ⚠️ BEWARE OF RETATRUTIDE SOLD

Clinical efficacy and body composition changes with sodium glucose cotransporter 2 inhibitor/glucagon-like peptide-1 agonist combination therapy in patients with type 2 diabetes mellitus-associated nonalcoholic fatty liver disease

Elevated Amylase and Lipase Levels in Patients Using Glucagonlike Peptide-1 Receptor Agonists or Dipeptidyl-Peptidase-4 Inhibitors in the Outpatient Setting

Rybelsus is the first oral semaglutide approved by the FDA to improve blood sugar control in adults with type 2 diabetes

Gradually increase your daily fiber intake with vegetables, fruits (with skin), and whole grains

Nature 583 , 441446

We look forward to the journey with these companies innovating for a brighter, more technologically advanced future. The finalists were selected from an initial pool of approximately 1,300 applicants